Biodesix Analyst Price Targets - Benzinga

SPY757.12+0.19%QQQ692.74+0.33%BTC/USD78,000.38+0.73%DIA517.65+0.10%GLD356.15+0.10%TLT81.65−0.23%

Premium Services

Biodesix Inc

BDSXNASDAQ

Trade with Public

Trade with Public

$23.25

-1.46-5.93%

Last update: Oct 30, 6:37 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Biodesix Analyst Price Targets

Wall Street analyst price targets and consensus rating for Biodesix (BDSX).

Price Target Range — 10 Quarters

Analyst Consensus — 7 Analysts

7Buy

Consensus RatingBuy# Analysts7Avg. Consensus PT$39Upside to Avg. PT+66.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 13, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$30→$40
Sep 25, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$27→$38
Aug 10, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$27→$35
Aug 6, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$26→$27
Jun 25, 2026	Roth Capital	Max Masucci	Initiate	Buy	$32
Jun 18, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$22→$27
Jun 15, 2026	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$26
May 5, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$20→$22
Feb 27, 2026	William Blair	Brian Weinstein	Upgrade	Market Perform→Outperform	—
Feb 17, 2026	Canaccord Genuity	Kyle Mikson	Maintained	Buy	$20
Sep 19, 2025	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$30→$20
May 21, 2025	Scotiabank	Sung Ji Nam	PT Cut	Sector Outperform	$60→$40
May 14, 2025	Craig-Hallum	Bill Bonello	PT Cut	Buy	$60→$30
May 14, 2025	Lake Street	Thomas Flaten	PT Cut	Buy	$60→$40
May 14, 2025	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$50→$30
May 14, 2025	William Blair	Brian Weinstein	Downgrade	Outperform→Market Perform	—
Apr 29, 2025	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$70→$50
Sep 16, 2024	Scotiabank	Sung Ji Nam	Initiate	Sector Outperform	$60
Jul 26, 2024	Craig-Hallum	Bill Bonello	Initiate	Buy	$60
May 13, 2024	TD Cowen	Dan Brennan	Initiate	Buy	$56

Analyst Ratings News

PRO
TD Cowen Maintains Buy on Biodesix, Raises Price Target to $40

TD Cowen analyst Dan Brennan maintains Biodesix (NASDAQ:BDSX) with a Buy and raises the price target from $30 to $40.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $35

Canaccord Genuity analyst Kyle Mikson maintains Biodesix (NASDAQ:BDSX) with a Buy and raises the price target from $27 to $35.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Biodesix, Raises Price Target to $27

HC Wainwright & Co. analyst Yi Chen maintains Biodesix (NASDAQ:BDSX) with a Buy and raises the price target from $26 to $27.

Benzinga Newsdesk

PRO
Roth Capital Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $32

Roth Capital analyst Max Masucci initiates coverage on Biodesix (NASDAQ:BDSX) with a Buy rating and announces Price Target of $32.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $27

Canaccord Genuity analyst Kyle Mikson maintains Biodesix (NASDAQ:BDSX) with a Buy and raises the price target from $22 to $27.

Benzinga Newsdesk

This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's analyst ratings page. See analyst views on ICUI, BDSX,.

Avi Kapoor